Veterinary Vaccines Market Expected to Reach $16.7 Billion by 2030 with 6% CAGR

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Bioengineered Protein Drugs Market Over The Period 2026–2030?

The veterinary vaccines market has demonstrated significant growth over recent years. This market is projected to expand from $12.54 billion in 2025 to $13.28 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.9%. The expansion observed in the past can be attributed to the increasing occurrence of animal diseases, a rising livestock population, the growing number of companion animals, government regulations that support vaccination, and advancements in vaccine research and production.

The veterinary vaccines market size is set for robust expansion over the next few years, with projections indicating growth to $16.79 billion in 2030, achieving a compound annual growth rate (CAGR) of 6.0%. This anticipated growth can be credited to factors such as evolving biopharmaceutical vaccine technologies, an increasing need for preventive veterinary care, the implementation of DNA and recombinant vaccines, the scaling up of vaccination campaigns in emerging markets, and heightened awareness regarding the prevention of zoonotic diseases. Key trends expected in this forecast period include the development of new livestock vaccines, a rise in companion animal vaccination initiatives, the wider availability of recombinant and toxoid vaccines, the adoption of multi-disease combination vaccines, and a concerted effort to prevent the transmission of zoonotic diseases.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2456&type=smp

What Drivers Are Expected To Influence The Bioengineered Protein Drugs Market During The Forecast Period?

The rising prevalence of various ailments among animals is anticipated to boost the veterinary vaccine market. This phenomenon involves non-human animals experiencing simultaneous or consecutive multiple pathological conditions, leading to compounded physical, psychological, and functional harm that severely compromises their welfare. The increase in animals suffering from diverse diseases is attributed to poor sanitation and hygiene conditions in animal habitats. Veterinary vaccines assist these animals by stimulating their immune systems to prevent infections, reduce disease severity, limit transmission, and enhance overall animal health and welfare. For instance, in July 2025, the UK Health Security Agency, a UK-based government agency, reported 154 confirmed and probable leptospirosis cases (a bacterial zoonotic infection) in 2024, marking an 11.6% increase from the 138 cases recorded in 2023. Consequently, the growing number of animals affected by a range of diseases is driving the expansion of the veterinary vaccine market.

How Is The Bioengineered Protein Drugs Market Divided Into Its Major Segments?

The veterinary vaccines market covered in this report is segmented –

1) By Vaccine Type: Live Attenuated, Inactivated (Killed), Recombinant Or Subunit, mRNA And DNA, Other Vaccine Types

2) By Animal Type: Canine, Feline, Equine, Bovine, Swine, Poultry, Other Animal Types

3) By Disease Type: Viral Diseases, Bacterial Diseases, Parasitic Diseases, Other Disease Types

4) By Route Of Administration: Injectable, Oral, Intranasal, Other Route Of Administrations

5) By End-User Or Customer Type: Pet Owners Or Companion Animal Owners, Farm Or Livestock Owners, Veterinary Clinics Or Hospitals, Animal Shelters Or Rescue Organizations, Research Or Educational Institutions

Subsegments:

1) By Live Attenuated: Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines

2) By Inactivated (Killed): Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines

3) By Recombinant Or Subunit: Viral Vaccines, Bacterial Vaccines

4) By mRNA And DNA: Viral Vaccines, Bacterial Vaccines

5) By Other Vaccine Types: Toxoid Vaccines, Conjugate Vaccines, Vector-based Vaccines

How Are Trends Transforming The Veterinary Vaccines Market Landscape?

Key players within the veterinary vaccine market are introducing novel products to establish a competitive edge. These new products encompass advanced and condition-specific veterinary vaccines that feature improved compositions, expanded pathogen coverage, and superior safety and efficacy attributes. For example, in June 2023, Merck Animal Health, a pharmaceutical company based in the US, unveiled Circumvent CML, a new three-in-one swine vaccine. This vaccine offers protection against Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsoniaintracellularis. It combines multiple antigens and adjuvant systems in a single bottle, which decreases the volume needed. Administered as a single intramuscular dose to pigs three weeks of age or older, it simplifies the vaccination process and reduces stress for both the animals and those caring for them.

Who Are The Prominent Organizations Shaping The Bioengineered Protein Drugs Market?

Major companies operating in the veterinary vaccines market are Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Santé Animale., Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, Bayer Animal Health, Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Jurox Pty Ltd, Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health, Interfeed, Biotex Plus Ltd., Belfarmacom, IDT Biologika, UCBVET, Lemavet, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, DBK Pharma S.A.E.

Read the full veterinary vaccines market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Which Region Is Forecast To Lead The Bioengineered Protein Drugs Market In Terms Of Market Size?

North America was the largest region in the veterinary vaccines market in 2025. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Bioengineered Protein Drugs Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2456&type=smp

Browse Through More Reports Similar to the Global Veterinary Vaccines Market 2026, By The Business Research Company

Companion Animal Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

Dog Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795